Bottom line
MEDX vs IYH: the short answer
MEDX (Horizon Kinetics Medical ETF) and IYH (iShares U.S. Healthcare ETF) share a meaningful slice of their top holdings — about 48% by weight.
But IYH is far broader, holding 103 positions to 33 for MEDX, so beyond the top names it adds exposure MEDX doesn't have.
IYH is cheaper at 0.37% vs 0.85% — a difference of $48 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +5.8% for MEDX.
Updated Nov 19, 2026
MEDX vs IYH side by side
| MEDX | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Roundhill | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.85% | 0.37% |
| Annual cost per $10k | $85 | $37 |
| 10-yr cost on $10k (prospectus) | $1,049 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.4% | +13.1% |
| 5-yr return (annualized) | +5.8% | +7.0% |
| 10-yr return (annualized) | +5.7% | +9.4% |
| Best quarter | +15.0% | +15.3% |
| Worst quarter | −12.9% | −12.7% |
| Net assets (fund) | $19.1M | $3.6B |
| Number of holdings | 33 | 103 |
| Portfolio turnover | % | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDX | IYH | Difference |
|---|---|---|---|
| 2025 | +28.4% | +13.1% | +15.3% |
| 2024 | −4.7% | +3.1% | −7.8% |
| 2023 | −6.0% | +2.1% | −8.1% |
| 2022 | +4.2% | −4.4% | +8.6% |
| 2021 | +10.6% | +23.4% | −12.8% |
| 2020 | +9.0% | +15.5% | −6.4% |
| 2019 | +16.0% | +20.8% | −4.8% |
| 2018 | +1.7% | +5.9% | −4.2% |
| 2017 | +10.7% | +22.3% | −11.6% |
| 2016 | −8.0% | −2.8% | −5.2% |
Source: Fund prospectus bar charts
Holdings overlap
8 of MEDX's top 25 holdings also appear in IYH's top 25.
| Holding | MEDX | IYH |
|---|---|---|
| Eli Lilly & Co | 18.46% | 15.11% |
| AbbVie Inc | 8.85% | 7.32% |
| Johnson & Johnson | 5.59% | 10.17% |
| Bristol-Myers Squibb Co | 4.42% | 2.20% |
| Merck & Co Inc | 3.96% | 5.31% |
| Amgen Inc | 3.91% | 3.42% |
| Pfizer Inc | 2.86% | 2.35% |
| Regeneron Pharmaceuticals Inc | 2.06% | 1.27% |
Source: SEC Form N-PORT
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between MEDX and IYH?
Which is cheaper, MEDX or IYH?
Should I own both MEDX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.